Irinotecan Hydrochloride 20 mg / ml Concentrate for Solution for Infusion

Licence status
Withdrawn: 28/08/2019
Active substances
Irinotecan hydrochloride trihydrate
Dosage Form
Solution for infusion
Licence number
PA2059/043/001
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX19 irinotecan
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
03/11/2008